You are invited to the ACGT Lunch Symposium, during the SITC Annual Conference. The ACGT Lunch is an opportunity for the cancer cell and gene community to reconnect during SITC and hear from leaders in the field.
We are honored to announce the ACGT SITC luncheon keynote speaker, Dr. Renier Brentjens, ACGT Research Fellow. Dr. Brentjens will participate in a fireside chat with ACGT board member Marc Engelsgjerd, MD.
We are delighted to also welcome Yvonne Chen, PhD, ACGT Research Fellow who will present who will present her work on Armored Chimeric Antigen Receptor T-cell Therapy Targets Antigen-Heterogeneous Glioma.
Please register today to secure your attendance!
AGENDA
11:30 – 11:45
Buffet lunch & networking
11:45 – 11:50
Alliance for Cancer Gene Therapy introduction
11:50– 12:20
Keynote - Fireside Chat with Renier Brentjens, MD, PhD, Deputy Director, Roswell Park Comprehensive Cancer Center.
Moderated by Marc Engelsgjerd, MD, Royalty Pharma, ACGT Board member.
12:20 – 12:50
Presentation: Armored Chimeric Antigen Receptor T-cell Therapy Targets Antigen-Heterogeneous Glioma, Yvonne Chen, PhD, Professor of Microbiology, Immunology, and Molecular Genetics, Professor of Chemical and Biomolecular Engineering and Co-Director of Tumor Immunology and Immunotherapy at the UCLA Health Jonsson Comprehensive Cancer Center.
12:50 – 1:00
Questions & discussion
1:10 – 1:30
Networking
We look forward to seeing you in-person at the ACGT lunch and during the SITC conference!